Skip to main content
TipRanks
Go Ultimate75% OFF

Synmosa Biopharma Corp (4114) Balance Sheet

Synmosa Biopharma Corp Balance Sheet

Synmosa Biopharma Corp's total assets for Q2 2026 were NT$15.28B, an increase of 8.80% from the previous quarter. TW:4114 total liabilities were NT$5.41B for the fiscal quarter, a 36.32% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 13.99BNT$ 12.30BNT$ 11.73BNT$ 11.20BNT$ 10.32B
NT$ 3.89BNT$ 3.91BNT$ 3.63BNT$ 4.55BNT$ 4.22B
NT$ 10.10BNT$ 8.40BNT$ 8.10BNT$ 6.65BNT$ 6.10B

Currency in TWD

Synmosa Biopharma Corp Liabilities to Assets

05B10B15B24 %32 %40 %48 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets